List view / Grid view

Melanoma & Skin Cancer

 

news

EC approves Cotellic plus Zelboraf in advanced melanoma

25 November 2015 | By Victoria White

The approval is based on data that showed Cotellic plus Zelboraf helped people with previously untreated BRAF V600 mutation-positive advanced melanoma live for more than a year without their disease worsening...

news

Merck announces findings from Keytruda combination studies

23 November 2015 | By Victoria White

The findings come from three studies investigating the use of Keytruda (pembrolizumab) in combination with three other immunotherapies – epacadostat, Imlygic (talimogene laherparepvec), and ipilimumab – in patients with advanced melanoma...